This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
SUO 2015
- Prostate Cancer
- Bladder Cancer
- Renal Cancer
- Penile Cancer
- Health Services
SUO 2015
Viewing 1-20 of 40 articles
SUO 2015 Oncologic surveillance following radical cystectomy: an individualized risk-based approach - Poster Session Highlights
SUO 2015 The Current Status of Adjuvant Systemic Therapy for RCC - Session Highlights
SUO 2015 Contemporary Utilization Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy and Bladder Preservation Therapy for Muscle Invasive Bladder Cancer - Poster Session Highlights
SUO 2015 Acute kidney injury after partial nephrectomy: the role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery - Poster Session Highlights
SUO 2015 Resection Techniques for Nephron Sparing Surgery Vary: Analysis of a Prospectively Collected Multi-Institutional International Cohort Harnessing the Surface–Intermediate–Base (S.I.B.) Margin Score - Poster Session Highlights
SUO 2015 Endoscopic versus surgical management for patients with upper tract urothelial cancer as their first cancer diagnosis: A matched propensity score analysis using SEER-Medicare data - Poster Session Highlights
SUO 2015 PARP Inhibitors and Prostate Cancer - Session Highlights
SUO 2015 Immunotherapy in Prostate Cancer: Clinical Advances - Session Highlights
SUO 2015 The Evolving Role of Chemotherapy in Advanced Prostate Cancer - Session Highlights
SUO 2015 Novel Approaches to Cytotoxic and Targeted Drugs in NMIBC - Session Highlights
SUO 2015 State of The Art Lecture 2 - Session Highlights
SUO 2015 State of the Art Lecture 1 - Session Highlights
SUO 2015 Improving Outcomes After Radical Prostatectomy - Session Highlights
SUO 2015 Impact of Renal Mass Biopsy on Renal Mass Management - Session Highlights
SUO 2015 Development of the Renal Cancer Follow-up Guidelines - Session Highlights
SUO 2015 Chronic Inflammation is Associated With Low Grade Prostate Cancer - Poster Session
SUO 2015 Does ERAS Level the Playing Field? - Session Highlights
SUO 2015 Pro Robotic Cystectomy - Session Highlights
SOU 2015 Pro Open Cystectomy - Session Highlights
SUO 2015 Combination Checkpoint Inhibitors - Session Highlights
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free